Nanologica AB (publ) (STO:NICA)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.3990
+0.0080 (2.05%)
At close: Mar 4, 2026
Market Cap34.55M -80.3%
Revenue (ttm)21.13M +44.8%
Net Income-51.29M
EPS-0.58
Shares Out88.37M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume34,966
Average Volume58,912
Open0.3990
Previous Close0.3910
Day's Range0.3910 - 0.4000
52-Week Range0.3700 - 1.9850
Beta-0.32
RSI36.42
Earnings DateFeb 12, 2026

About Nanologica AB

Nanologica AB (publ), a nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science industry in China, India, the United State of America, and internationally. It offers NLAB Saga, a new generation silica for preparative chromatography; and SVEA, a pre-packaged columns for analytical chromatography; and high-performance liquid chromatography, a separation method based on different substances in a solution passing through a column at different paces. The company provides products for the analysis and pu... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2004
Employees 19
Stock Exchange Nasdaq Stockholm
Ticker Symbol NICA
Full Company Profile

Financial Performance

In 2025, Nanologica AB's revenue was 21.05 million, an increase of 44.79% compared to the previous year's 14.54 million. Losses were -51.29 million, -21.85% less than in 2024.

Financial Statements